MDxHealth
In Brief This Week: MDxHealth, ERS Genomics, Helix, Cerca Biotech, Shuwen Biotech, More
News items for the week of Jan. 13, 2025.
GenomeWeb Top 40 Falls 3 Percent in December Amid Mixed Broader Market
The Dow Jones Industrial Average fell 5 percent while the Nasdaq rose by less than 1 percent, and the Nasdaq Biotech Index dropped 7 percent.
Updated NCCN Guidelines Adjust Ratings for Prostate Cancer Genetic Tests
The newest version ups its endorsement of somatic genomic testing to "recommended" for advanced cancers and shifts its recommendations on early-stage risk assays.
MDxHealth Raises Full-Year Guidance as Revenues Increase 21 Percent in Q3
Tissue-based tests comprised 80 percent of the firm's Q3 revenues, while volumes in that category rose 36 percent year over year.
GenomeWeb Top 40 Rises 2 Percent in September, Largely Tracking Broader Market
Of the 40 firms tracked by GenomeWeb, 21 saw their stock prices rise month over month and 19 saw their shares decrease in value.
Sep 25, 2024
MDxHealth Prices $40M Ordinary Share Public Offering
Aug 22, 2024
MDxHealth Q2 Revenues Rise 33 Percent
Apr 3, 2023